Advertisement
Screener

MaxCyte, Inc. (MXCT) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

MaxCyte, Inc. Cash Flow Breakdown

Cash flow breakdown shows where MaxCyte, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $34.41M went out.
  • Fiscal year ended 2025-12-31: from investing, $25.93M came in.
  • Fiscal year ended 2025-12-31: from financing, $656.00K came in.
  • Fiscal year ended 2025-12-31: change in cash, $7.82M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$34.41M$25.93M$432.00K-$7.82M
2024-12-31-$27.61M$6.93M$1.60M-$18.62M
2023-12-31-$21.69M$54.98M$1.87M$35.44M
2022-12-31-$14.78M-$24.82M$2.89M-$36.72M
2021-12-31-$10.68M-$195.01M$51.81M$182.91M*$29.03M
2020-12-31-$8.78M-$16.58M$28.57M$3.54M
2019-12-31-$8.80M$454.50K$12.33M$3.96M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2026-06-30-$4.66M*$6.57M*$24.00K*-$1.44M*
2026-03-31-$8.17M$2.66M$5.00K-$5.51M
2025-12-31-$2.69M*$9.68M*$15.00K*
2025-09-30-$7.46M*$5.19M*$14.00K*
2025-06-30-$9.85M*$1.54M*$20.00K*
2025-03-31-$14.41M$9.53M$383.00K-$4.50M
2024-12-31-$7.82M*-$1.67M*$218.00K*
2024-09-30-$4.39M*$3.61M*$228.00K*
2024-06-30-$4.83M*$19.39M*$448.00K*
2024-03-31-$10.56M-$14.40M$703.00K-$24.26M
2023-12-31$981.00K*-$4.14M*$224.00K*
2023-09-30-$8.24M*$2.81M*$37.00K*
2023-06-30-$10.11M*$26.67M*$157.00K*
2023-03-31-$4.32M$29.64M$1.46M$26.77M
2022-12-31-$6.09M*-$27.09M*$1.23M*
2022-09-30-$5.92M*-$60.67M*$444.40K*
2022-06-30$918.60K*-$131.85M*$325.50K*
2022-03-31-$3.69M$194.80M$892.60K$191.99M
2021-12-31-$960.25K*-$11.44M*-$184.27M*$185.48M*
2021-09-30-$690.45K*-$162.35M*$184.27M*
2021-06-30-$4.39M*-$36.92M*$0.00*
2021-03-31-$4.64M$15.69M-$260.00K$51.81M-$2.65M*$59.95M
2020-12-31-$1.91M*-$376.30K*$0.00*
2020-09-30-$830.30K*-$16.65M*$0.00*

Similar stocks

Stock NameCountryMarket CapPE Ratio
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
NRC HEALTH (NRC)United States$0.450B42.50
OmniAb, Inc. (OABI)United States$0.698B-8.05
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14